Study of Radiation Exposure and Bilateral Breast Cancer

Active, not recruitingOBSERVATIONAL
Enrollment

1,699

Participants

Timeline

Start Date

May 31, 2009

Primary Completion Date

May 31, 2026

Study Completion Date

May 31, 2026

Conditions
Breast Cancer
Interventions
OTHER

questionaire, blood or saliva sample

Take part in an approximately 45 minute telephone interview, with questions about detailed treatment (chemotherapy, hormonal therapy, radiation therapy (RT)) for all study participants. Their medical records will be reviewed to get further details about treatment of their breast cancer. They donate either a 35 ml blood sample (about 3 tablespoons) or a saliva sample. Blood Sample: if patient consents to give a blood sample, following the interview, they will be contacted by our staff phlebotomist (a person trained to draw blood). A scheduled appointment to draw a blood sample from you at your home. At the time of the blood draw, the phlebotomist will collect approximately 2 and 1/3 tablespoons of blood. Saliva Sample: if they choose not to give a blood sample, but consent to give a saliva sample instead, a saliva kit will be sent to there home. Once they provide the sample in the kit, they will be asked to mail back the sample in the pre-labeled kit that was sent to them.

Trial Locations (6)

10065

Memorial Sloan Kettering Cancer Center, New York

52242

University of Iowa, Iowa City

94305

Stanford University, Stanford

98109

Fred Hutchinson Cancer Research Center, Seattle

M5G 1X5

ONTARIO CANCER REGISTRY, Mount Sinai Hospital, Toronto, Toronto

Unknown

Danish Cancer Society, Copenhagen

Sponsors
All Listed Sponsors
collaborator

Translational Genomics Research Institute

OTHER

collaborator

University of Southern California

OTHER

collaborator

University of Virginia

OTHER

collaborator

Lund University

OTHER

collaborator

Ontario Cancer Registry (OCR) and Mount Sinai Hospital- Toronto (MSHT)

UNKNOWN

collaborator

Northern California Cancer Center

OTHER

collaborator

Fred Hutchinson Cancer Center

OTHER

collaborator

University of Iowa

OTHER

collaborator

Danish Cancer Society

OTHER

collaborator

Beckman Research Institute

OTHER

collaborator

City of Hope National Medical Center

OTHER

collaborator

M.D. Anderson Cancer Center

OTHER

collaborator

Vanderbilt University School of Medicine

OTHER

collaborator

NYU Langone Health

OTHER

collaborator

University of Chicago

OTHER

collaborator

University of California, Irvine

OTHER

collaborator

Stanford University

OTHER

lead

Memorial Sloan Kettering Cancer Center

OTHER